BioLytical Laboratories has previously developed processes for fast detection of HIV and Ebola viruses
Richmond-based medical tech company BioLytical Laboratories has filed two patent applications in the US for its new Zika virus detection method.
“It is important to have innovative and relevant technologies at a state of readiness to enable a rapid response to emerging infectious disease like the Zika virus outbreak,” said Rick Galli, the company’s chief technical officer.